What is the intrinsic value of CDBT?
As of 2025-08-03, the Intrinsic Value of China Dasheng Biotechnology Co (CDBT) is
3.02 USD. This CDBT valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.03 USD, the upside of China Dasheng Biotechnology Co is
9,666.75%.
Is CDBT undervalued or overvalued?
Based on its market price of 0.03 USD and our intrinsic valuation, China Dasheng Biotechnology Co (CDBT) is undervalued by 9,666.75%.
CDBT Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
3.02 - 3.02 |
3.02 |
9,666.75% |
| DDM - Stable |
0.55 - 1.33 |
0.94 |
2948.8% |
| DDM - Multi |
0.00 - 0.00 |
0.00 |
-100.0% |
CDBT Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1.64 |
| Beta |
0.81 |
| Outstanding shares (mil) |
53.07 |
| Enterprise Value (mil) |
-8.77 |
| Market risk premium |
4.60% |
| Cost of Equity |
12.20% |
| Cost of Debt |
5.00% |
| WACC |
7.94% |